Company profile
Astrivax Therapeutics
- Industry
- Biotechnology Research
- Employees
- 34
- Headquarters
- Leuven, Flemish Region
- LinkedIn followers
- 4,280
- Office locations
- 1
Astrivax Therapeutics company summary
Astrivax Therapeutics is a company in the Biotechnology Research industry, headquartered in Leuven, Flemish Region. On LinkedIn the company has around 34 employees and 4,280 followers.
What technology does Astrivax Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Astrivax Therapeutics
Astrivax Therapeutics (Astrivax) is a clinical-stage biopharmaceutical company on a mission to end virus-driven cancer, the second leading preventable cause of cancer after smoking. Its clinically validated Launch-iT platform generates durable, antigen-specific T-cell responses that clear virus-infected cells, supported by a scalable, tech-transfer–ready manufacturing process. Astrivax’s lead program targets human papillomavirus 16 (HPV16), a leading cause of virus-driven cancers, including cervical cancer and head and neck cancer. The company is advancing its platform toward clinical proof-of-concept for persistent HPV infections and plans to expand across additional HPV-driven cancers. Beyond oncology, Astrivax is exploring applications in autoimmune diseases where viral infections are increasingly recognized as drivers of disease.
Where is Astrivax Therapeutics located?
Astrivax Therapeutics lists 1 location.
Compare companies similar to Astrivax Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Astrivax Therapeutics astrivax.com | Biotechnology Research | 34 | - | Leuven, Flemish Region |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Astrivax Therapeutics
What does Astrivax Therapeutics do?
Astrivax Therapeutics (Astrivax) is a clinical-stage biopharmaceutical company on a mission to end virus-driven cancer, the second leading preventable cause of cancer after smoking. Its clinically validated Launch-iT platform generates durable, antigen-specific T-cell responses that clear virus-infected cells, supported by a scalable, tech-transfer–ready manufacturing process. Astrivax’s lead program targets human papillomavirus 16 (HPV16), a leading cause of virus-driven cancers, including cervical cancer and head and neck cancer. The company is advancing its platform toward clinical proof-of-concept for persistent HPV infections and plans to expand across additional HPV-driven cancers. Beyond oncology, Astrivax is exploring applications in autoimmune diseases where viral infections are increasingly recognized as drivers of disease.
How many employees does Astrivax Therapeutics have?
Astrivax Therapeutics has around 34 employees on LinkedIn.
Where is Astrivax Therapeutics headquartered?
Astrivax Therapeutics is headquartered in Leuven, Flemish Region.
Build a lead list from companies like Astrivax Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.